Treatable

Cyclophosphamide

Alkylating Drug

Cyclophosphamide oral capsule

Cyclophosphamide injection

Cyclophosphamide oral tablet

Cyclophosphamide injectable solution

DosageBrandImage
cyclophosphamide 200 MG/ML Generic

Cyclophosphamide side effects

Adverse Event ReportedReporting Odds RatioCase Count
Maternal exposure before pregnancy36.62623233
Venoocclusive disease23.14808230
Chronic graft versus host disease22.14482384
Acute graft versus host disease21.97506613
Venoocclusive liver disease20.42696385
Cystitis haemorrhagic20.30522343
Acute graft versus host disease in skin19.37344331
Haematotoxicity18.54094425
Stem cell transplant18.17076322
Graft versus host disease17.68089744
Hepatitis B17.43556462
Progressive multifocal leukoencephalopathy16.1601464
Febrile neutropenia12.745933756
Myelodysplastic syndrome12.26424846
Neutropenic sepsis11.8665466
Tumour lysis syndrome10.76167319
Pneumocystis jiroveci pneumonia10.69045401
Mucosal inflammation8.712821073
Cytomegalovirus infection8.70553610
Neurotoxicity8.57501294
Neutropenia7.34133002
Bone marrow failure7.13473670
Lymphopenia7.01743318
Disease recurrence6.48207456
Neutrophil count decreased5.15215701
Pneumonitis4.8136394
Pancytopenia4.243541272
Leukopenia4.20828917
Palmar-plantar erythrodysaesthesia syndrome4.20425296
Hepatotoxicity4.15238258

Cyclophosphamide desired effects:

  • Decreased DNA Replication
  • Decreased DNA Integrity

Cyclophosphamide drug classes:

  • Alkylating Drug

Cyclophosphamide pharmacologic actions:

  • Antineoplastic Agents, Alkylating
  • Antirheumatic Agents
  • Myeloablative Agonists
  • Immunosuppressive Agents

Cyclophosphamide mechanism of action:

  • Alkylating Activity
  • treatable

Copyright © Treatable 2021
Last updated: 7/25/2021, 2:11:32 AM